Learning and Education to ADvance and Empower Rare Disease Drug Developers (LEADER 3D) CDER’s ARC Program | Center for Drug Evaluation and Research +++

https://www.fda.gov/about-fda/accelerating-rare-disease-cures-arc-program/learning-and-education-advance-and-empower-rare-disease-drug-developers-leader-3d?utm_medium=email&utm_source=govdelivery Opportunity for Public Comment on Rare Disease Educational Materials from the Center for Drug Evaluation and Research’s Accelerating Rare disease Cures Program and the Rare Disease Innovation Hub Posted by the Food and Drug Administration on Feb 11, 2026 https://www.regulations.gov/document/FDA-2026-N-1584-0001?utm_medium=email&utm_source=govdelivery FDA Rare Disease Innovation Hub https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/fda-rare-disease-innovation-hub?utm_medium=email&utm_source=govdelivery